Short Interest in Arcadia Biosciences, Inc. (NASDAQ:RKDA) Expands By 297.4%

Arcadia Biosciences, Inc. (NASDAQ:RKDA) saw a large growth in short interest during the month of April. As of April 30th, there was short interest totaling 6,339 shares, a growth of 297.4% from the April 15th total of 1,595 shares. Based on an average trading volume of 39,192 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.3% of the shares of the stock are short sold.

Analysts Set New Price Targets

Separately, Weiss Ratings raised shares of Arcadia Biosciences from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, May 6th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Arcadia Biosciences has an average rating of “Sell”.

Arcadia Biosciences Price Performance

Shares of RKDA remained flat at $1.06 during mid-day trading on Wednesday. The stock had a trading volume of 29,205 shares, compared to its average volume of 33,129. Arcadia Biosciences has a 12 month low of $0.89 and a 12 month high of $6.71. The firm has a market capitalization of $2.18 million, a price-to-earnings ratio of -0.62 and a beta of 0.52. The business has a 50 day moving average of $1.42 and a 200-day moving average of $2.35.

Arcadia Biosciences (NASDAQ:RKDA) last posted its quarterly earnings data on Thursday, March 26th. The basic materials company reported ($0.98) earnings per share for the quarter, missing the consensus estimate of ($0.66) by ($0.32). Arcadia Biosciences had a negative net margin of 48.15% and a positive return on equity of 37.36%. The business had revenue of $0.90 million during the quarter, compared to the consensus estimate of $1.40 million.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.